Factors associated with testing of COPD patients for serum AAT levels to detect cases of AATD. The EPOCONSUL study.
G. Vargas Centanaro (MADRID, Spain), J. Rodriguez Hermosa (Madrid, Spain), J. Soriano (Madrid, Spain), J. López- Campos (Sevilla, Spain), J. Soler Cataluña (Valencia , Spain), J. Rodríguez Gonzalez Moro (Granada, Spain), B. Alcázar Navarrete (Madrid, Spain), M. Calle Rubio (Madrid, Spain)
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Session: COPD phenotypes: a1 antitrypsin deficiency and beyond
Session type: Poster Discussion
Number: 570
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Vargas Centanaro (MADRID, Spain), J. Rodriguez Hermosa (Madrid, Spain), J. Soriano (Madrid, Spain), J. López- Campos (Sevilla, Spain), J. Soler Cataluña (Valencia , Spain), J. Rodríguez Gonzalez Moro (Granada, Spain), B. Alcázar Navarrete (Madrid, Spain), M. Calle Rubio (Madrid, Spain). Factors associated with testing of COPD patients for serum AAT levels to detect cases of AATD. The EPOCONSUL study.. 570
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: